Stock Split History
Checkpoint Therapeutics stock split history picture
Checkpoint Therapeutics (CKPT) has 1 split in our Checkpoint Therapeutics stock split history database. The split for CKPT took place on December 06, 2022. This was a 1 for 10 reverse split, meaning for each 10 shares of CKPT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Checkpoint Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Checkpoint Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Checkpoint Therapeutics shares, starting with a $10,000 purchase of CKPT, presented on a split-history-adjusted basis factoring in the complete Checkpoint Therapeutics stock split history. Checkpoint Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/28/2017
End date: 03/28/2024
Start price/share: $100.00
End price/share: $2.05
Dividends collected/share: $0.00
Total return: -97.95%
Average Annual Total Return: -43.76%
Starting investment: $10,000.00
Ending investment: $205.09
Years: 6.75
Checkpoint Therapeutics is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of treatments for patients with solid tumor cancers. Co. is evaluating its primary antibody product candidate, cosibelimab, an anti-programmed death-ligand 1 antibody, in an ongoing global, open-label, multicohort clinical trial in checkpoint therapy-naive patients with selected recurrent or metastatic cancers. Co. is also evaluating its main small-molecule, targeted anti-cancer agent, olafertinib, an epidermal growth factor receptor (EGFR) inhibitor, as a potential treatment for patients with EGFR mutation-positive non-small cell lung cancer. According to our Checkpoint Therapeutics stock split history records, Checkpoint Therapeutics has had 1 split.
Date Ratio
12/06/20221 for 10
CKPT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CLBS Split History
CLDN Split History
CLDX Split History
CLRB Split History
CLRBW Split History
CLSN Split History
CMD Split History
CMN Split History
CNC Split History
CNDO Split History

Also explore: CKPT shares outstanding history

Email EnvelopeFree CKPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

NRx Pharmaceuticals, Inc. (NRXP)
Tritium DCFC Limited (DCFC)
Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Checkpoint Therapeutics
Checkpoint Therapeutics Insider Buying

Checkpoint Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.